+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Drug Discovery Technologies Market Research Report by Technology (Bioanalytical Instruments, Biochips, and Bioinformatics), End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4896655
  • Report
  • April 2022
  • Region: Global
  • 183 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022
The Global Drug Discovery Technologies Market size was estimated at USD 55.15 billion in 2021, USD 60.92 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.63% to reach USD 101.15 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Drug Discovery Technologies to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the market was studied across Bioanalytical Instruments, Biochips, Bioinformatics, Combinatorial Chemistry, Genomics, High Throughput Screening, Nanotechnology, Pharmacogenomics, and RNAI.
  • Based on End User, the market was studied across Biopharmaceutical Companies, Biotech Companies, Pharmaceutical Companies, and Research Institutes.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Drug Discovery Technologies market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Drug Discovery Technologies Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Drug Discovery Technologies Market, including Abbott Laboratories, Inc., Affymetrix Inc., Agilent Technologies, Inc, Albany Molecular Research Inc., Arqule Inc., AstraZeneca Plc, Bayer Healthcare AG, GE Healthcare Ltd., Luminex Corporation, and Novartis AG.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Drug Discovery Technologies Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Discovery Technologies Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Discovery Technologies Market?
4. What is the competitive strategic window for opportunities in the Global Drug Discovery Technologies Market?
5. What are the technology trends and regulatory frameworks in the Global Drug Discovery Technologies Market?
6. What is the market share of the leading vendors in the Global Drug Discovery Technologies Market?
7. What modes and strategic moves are considered suitable for entering the Global Drug Discovery Technologies Market?
Frequently Asked Questions about the Global Drug Discovery Technologies Market

What is the estimated value of the Global Drug Discovery Technologies Market?

The Global Drug Discovery Technologies Market was estimated to be valued at $55.2 Billion in 2021.

What is the growth rate of the Global Drug Discovery Technologies Market?

The growth rate of the Global Drug Discovery Technologies Market is 10.6%, with an estimated value of $101.2 Billion by 2027.

What is the forecasted size of the Global Drug Discovery Technologies Market?

The Global Drug Discovery Technologies Market is estimated to be worth $101.2 Billion by 2027.

Who are the key companies in the Global Drug Discovery Technologies Market?

Key companies in the Global Drug Discovery Technologies Market include Abbott Laboratories, Inc., Affymetrix Inc., Agilent Technologies, Inc, Albany Molecular Research Inc., Arqule Inc., AstraZeneca Plc, Bayer Healthcare AG, GE Healthcare Ltd. and Novartis AG.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of diseases
5.1.1.2. Increased demand for drug and biologics due to benefits, such as highly effective and potent action, and fewer side effects
5.1.1.3. Increasing research and development expenditure and investment for development of novel drug molecules
5.1.2. Restraints
5.1.2.1. High initial setup cost for drug discovery and development
5.1.2.2. Need of long duration of drug discovery process
5.1.3. Opportunities
5.1.3.1. Patent expiries of several drugs
5.1.3.2. Advances in the fields of biotechnology, molecular biology, nanotechnology, and genomics
5.1.4. Challenges
5.1.4.1. Presence of stringent regulatory environment
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Drug Discovery Technologies Market, by Technology
6.1. Introduction
6.2. Bioanalytical Instruments
6.3. Biochips
6.4. Bioinformatics
6.5. Combinatorial Chemistry
6.6. Genomics
6.7. High Throughput Screening
6.8. Nanotechnology
6.9. Pharmacogenomics
6.10. RNAI
7. Drug Discovery Technologies Market, by End User
7.1. Introduction
7.2. Biopharmaceutical Companies
7.3. Biotech Companies
7.4. Pharmaceutical Companies
7.5. Research Institutes
8. Americas Drug Discovery Technologies Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Drug Discovery Technologies Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Drug Discovery Technologies Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Abbott Laboratories, Inc.
12.2. Affymetrix Inc.
12.3. Agilent Technologies, Inc
12.4. Albany Molecular Research Inc.
12.5. Arqule Inc.
12.6. AstraZeneca Plc
12.7. Bayer Healthcare AG
12.8. GE Healthcare Ltd.
12.9. Luminex Corporation
12.10. Novartis AG
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: DYNAMICS
FIGURE 2. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 3. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 5. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOCHIPS, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOCHIPS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOINFORMATICS, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY GENOMICS, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY GENOMICS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY NANOTECHNOLOGY, 2019-2027 (USD BILLION)
FIGURE 18. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACOGENOMICS, 2019-2027 (USD BILLION)
FIGURE 20. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 21. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RNAI, 2019-2027 (USD BILLION)
FIGURE 22. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RNAI, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 23. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 24. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2027
FIGURE 26. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOTECH COMPANIES, 2019-2027 (USD BILLION)
FIGURE 29. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2019-2027 (USD BILLION)
FIGURE 31. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, 2019-2027 (USD BILLION)
FIGURE 33. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 34. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 35. ARGENTINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 36. BRAZIL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 37. CANADA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 38. MEXICO DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 39. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 40. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 41. AUSTRALIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. CHINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. INDIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. INDONESIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. JAPAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. MALAYSIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. PHILIPPINES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. SINGAPORE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. SOUTH KOREA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. TAIWAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. THAILAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. FRANCE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. GERMANY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. ITALY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. NETHERLANDS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. QATAR DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. RUSSIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. SAUDI ARABIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. SOUTH AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. SPAIN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. UNITED ARAB EMIRATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. UNITED KINGDOM DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: FPNV POSITIONING MATRIX
FIGURE 65. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOCHIPS, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOCHIPS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOCHIPS, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOCHIPS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOCHIPS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOINFORMATICS, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY REGION, 2019-2027 (USD BILLION)
TABLE 20. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY STATE, 2019-2027 (USD BILLION)
TABLE 22. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY GENOMICS, BY REGION, 2019-2027 (USD BILLION)
TABLE 25. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY GENOMICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY GENOMICS, BY STATE, 2019-2027 (USD BILLION)
TABLE 27. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY GENOMICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY GENOMICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2019-2027 (USD BILLION)
TABLE 30. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY STATE, 2019-2027 (USD BILLION)
TABLE 32. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 35. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY NANOTECHNOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY NANOTECHNOLOGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 37. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY NANOTECHNOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY NANOTECHNOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2019-2027 (USD BILLION)
TABLE 40. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACOGENOMICS, BY STATE, 2019-2027 (USD BILLION)
TABLE 42. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RNAI, BY REGION, 2019-2027 (USD BILLION)
TABLE 45. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RNAI, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 46. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RNAI, BY STATE, 2019-2027 (USD BILLION)
TABLE 47. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RNAI, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RNAI, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 50. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 51. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 53. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 56. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOTECH COMPANIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 58. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 61. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 63. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2019-2027 (USD BILLION)
TABLE 66. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY STATE, 2019-2027 (USD BILLION)
TABLE 68. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 70. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 71. ARGENTINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 72. BRAZIL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 73. CANADA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 74. MEXICO DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 75. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 76. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 77. AUSTRALIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 78. CHINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 79. INDIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 80. INDONESIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 81. JAPAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 82. MALAYSIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 83. PHILIPPINES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 84. SINGAPORE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 85. SOUTH KOREA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 86. TAIWAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 87. THAILAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 89. FRANCE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 90. GERMANY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 91. ITALY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 92. NETHERLANDS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 93. QATAR DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. RUSSIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 95. SAUDI ARABIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 96. SOUTH AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 97. SPAIN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 98. UNITED ARAB EMIRATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 99. UNITED KINGDOM DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 100. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: SCORES
TABLE 101. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: BUSINESS STRATEGY
TABLE 102. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: PRODUCT SATISFACTION
TABLE 103. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: RANKING
TABLE 104. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 105. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: MERGER & ACQUISITION
TABLE 106. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 107. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 108. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: INVESTMENT & FUNDING
TABLE 109. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 110. GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories, Inc.
  • Affymetrix Inc.
  • Agilent Technologies, Inc
  • Albany Molecular Research Inc.
  • Arqule Inc.
  • AstraZeneca Plc
  • Bayer Healthcare AG
  • GE Healthcare Ltd.
  • Luminex Corporation
  • Novartis AG

Methodology

Loading
LOADING...